HVTN 055

A Phase I trial to evaluate the safety and immunogenicity of rMVA-HIV (rMVA-HIV env/gag + rMVA-HIV tat/rev/nef-RT) and rFPV-HIV (rFPV-HIV env/gag + rFPV-HIV tat/rev/nef-RT) vaccines, alone or in combination, in healthy, vaccinia naive HIV-1 negative participants

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) July 01, 2004
TBC-M335,TBC-M358,TBC-F349,TBC-F357 MVA tat, rev ,nef, rt B; MVA env, gag, B; FPV tat, rev,nef, rt B; FPV env , gag B
TBC-M335 Viral Vector - Pox
TBC-M358 Viral Vector - Pox
TBC-F357 Viral Vector - Pox
Brazil, USA 150